Transcription of HIGHLIGHTS OF PRESCRIBING INFORMATION potentially ...
{{id}} {{{paragraph}}}
Example: stock market
HIGHLIGHTS OF PRESCRIBING INFORMATION potentially ...
HIGHLIGHTS OF PRESCRIBING INFORMATIONT hese HIGHLIGHTS do not include all the INFORMATION needed to use rotateq safely and effectively. See full PRESCRIBING INFORMATION for ( rotavirus Vaccine, Live, Oral, Pentavalent)Oral SolutionInitial Approval: 2006---------------------------INDICATIO NS AND USAGE ---------------------------- rotateq is a vaccine indicated for the prevention of rotavirus gastroenteritis caused by typesG1, G2, G3, G4, and G9.(1) rotateq is approved for use in infants 6 weeks to 32 weeks of age.(1)-----------------------DOSAGE AND ADMINISTRATION------------------------ FOR ORAL USE ONLY. NOT FOR INJECTION. (2) The vaccination seriesconsists of three ready-to-use liquid doses of rotateq administeredorally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4- to 10-week intervals.
2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE RotaTeq® is indicated for the prevention of rotavirus gastroenteritis in infants and children caused by
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: